MediPharm Labs Corp LABS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LABS is a good fit for your portfolio.
News
-
MediPharm Labs Provides Conference Call Recording Details
-
MediPharm Labs Reports Fourth Quarter and Full Year Results
-
MediPharm Labs Provides Update on German Cannabis Legalization
-
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results
-
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
-
Medical cannabis may help manage fibromyalgia, study finds
Trading Information
- Previous Close Price
- CAD 0.08
- Day Range
- CAD 0.08–0.08
- 52-Week Range
- CAD 0.06–0.10
- Bid/Ask
- CAD 0.08 / CAD 0.08
- Market Cap
- CAD 32.32 Mil
- Volume/Avg
- 228,800 / 237,433
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 166
- Website
- https://www.medipharmlabs.com
Valuation
|
Metric
|
LABS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.61 |
Price/Sales | 0.88 |
Price/Cash Flow | — |
Price/Earnings
LABS
Financial Strength
|
Metric
|
LABS
|
|---|---|
Quick Ratio | 2.20 |
Current Ratio | 3.37 |
Interest Coverage | −37.90 |
Quick Ratio
LABS
Profitability
|
Metric
|
LABS
|
|---|---|
Return on Assets (Normalized) | −20.56% |
Return on Equity (Normalized) | −24.73% |
Return on Invested Capital (Normalized) | −24.78% |
Return on Assets
LABS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bfnppvwg | Xhq | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Clqhcfxxks | Ttncp | $70.8 Bil | |
HLN
| Haleon PLC ADR | Sfmrbhqwx | Mdkd | $38.2 Bil | |
VTRS
| Viatris Inc | Xjcjwqx | Hxfts | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tnnfkww | Mckgx | $12.5 Bil | |
CTLT
| Catalent Inc | Jxzxssfy | Skpbd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nlrwqpxn | Kgtr | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Qhdkchqf | Rbmgq | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vzmptcxj | Ytjmkg | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fvbxkbxsz | Jdl | $2.9 Bil |